Linden Capital Partners in the acquisition of BioIVT, a market leading provider of mission critical biological specimens for the pharmaceutical discovery and development market.
Linden Capital Partners in the strategic investment in Vital Care (a leading franchisor of infusion therapy pharmacies) by funds managed by Berkshire Partners and Leonard Green & Partners.
Waud Capital Partners in its sale of a controlling ownership stake in GI Alliance (a leading gastroenterology practice management company, “GIA”), as part of a physician-led buyout and recapitalization valuing GIA at $2.2 billion and facilitated by an investment from funds managed by Apollo (NYSE: APO).
Waud Capital Partners in the sale of Heart + Paw to Whistler Capital Partners.
Insignia Capital Group in its sale of Market Performance Group (a highly regarded omnichannel commerce agency providing a full suite of outsourced services to blue-chip and high-growth CPG companies) to Sentinel Capital Partners.
Bain Capital in its equity investment in II-VI’s acquisition of Coherent.
Bain Capital in its investment in Kestra Medical Technologies.
Bain Capital-backed Kestra Medical Technologies in connection with an investment co-led by Andera Partners, Ally Bridge Group, Longitude Capital and Omega Funds with participation from T. Rowe Price Investment Management, Inc., Eventide Asset Management and Gilmartin Capital.
GTCR in the strategic investment in Resonetics, Inc. by funds managed by Carlyle, valuing the company at approximately $2.25 billion.
Thoma Bravo in its acquisition of HCSS, a leading supplier of estimating, operations, and fleet management software.
Shorehill Capital in its sale of Belt Power (largest independent lightweight conveyor belting and automation solutions platform) to Platte River Equity.
